High quality studies indicate that Garlic may reduce the risk of a wide variety of cancers in humans

January 14, 2009
Research was reviewed using the FDA’s evidence-based review system for the scientific evaluation of health claims. The search reviewed evidence published up until 2007 and only included human studies published in Korean or English (this of course leaves out the many studies published in Japanese and German). Of the 19 high quality human studies there was some evidence for reduction of risk of developing cancers of the colon, prostate, esophagus, larynx, ovaries, and kidney (renal cell carcinoma). To make an FDA allowable claim more studies are needed. The results are published in the December 3rd 2008 issue of the American Journal of Clinical Nutrition.